Stay updated on Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3 on the page. This update does not change any study details or visible content.
    Difference
    0.0%
    Check dated 2026-07-04T03:48:32.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.2, indicating a software/feature update of the page; the change does not modify the study details or displayed data.
    Difference
    0.0%
    Check dated 2026-06-26T23:19:15.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    New navigation/help sections have been added (How to Read a Study Record, Common Questions, How to Join a Study) and a statement now indicates that the site is no longer looking for participants. The Intervention/Treatment heading formatting was adjusted, and the page's revision tag updated to v3.6.0 (replacing the previous v3.5.5).
    Difference
    0.2%
    Check dated 2026-06-12T14:25:47.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, indicating a small update to the page's revision history.
    Difference
    0.0%
    Check dated 2026-06-05T11:25:02.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    A new Revision: v3.5.4 entry was added and the previous Revision: v3.5.3 entry was removed, updating the page to reflect the latest release version.
    Difference
    0.0%
    Check dated 2026-05-14T23:01:19.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The revision tag was updated from v3.5.2 to v3.5.3, signaling an updated release of the page's documentation/assets. This is an administrative update and does not reflect changes to study content or data.
    Difference
    0.0%
    Check dated 2026-04-30T17:18:44.000Z thumbnail image

Stay in the know with updates to Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page.